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Abstract 
Rapidly progressive acute respiratory failure attributed to 2009 H1N1 influenza A infection has been reported worldwide1-3. Refractory hypoxaemia
despite conventional mechanical ventilation and lung protective strategies has resulted in the use a combination of rescue therapies, such as
conservative fluid management, prone positioning, inhaled nitric oxide, high frequency oscillatory ventilation and extracorporeal membrane
oxygenation (ECMO)4. ECMO allows for pulmonary or cardiopulmonary support as an adjunct to respiratory and cardiac failure, minimising ventilator-
associated lung injury (VALI). This permits treatment of the underlying disease process, while concurrently allowing for recovery of the acute lung injury.
This case documents a previously healthy twenty-two year old Asian male patient with confirmed pandemic (H1N1) 2009 influenza A who was
successfully managed with ECMO in the setting of severe refractory hypoxaemia and progressive hypercapnia.
Case Report
A 22 year old previously healthy Chinese student presented to the Emergency Department with a 6 day history of worsening dyspnoea, myalgia and
general malaise. On examination he was found to be pyrexic (38.5°C), hypotensive (100/67 mmHg) and pulse oximetry recorded oxygen saturations of
78% on room air. His admission chest radiograph (Figure 1) showed bilateral middle and lower zone consolidation and arterial blood gas sample
confirmed severe hypoxaemia (PaO2 5.9 kPa). The patient was promptly transferred to the Intensive Care Unit for invasive ventilatory and vasopressor
support. Oseltamivir was commenced for confirmed pandemic H1N1 2009 influenza A infection, in addition to piperacillin/tazobactam, and
clarithromycin for community-acquired pneumonia. 
Figure 1: Admission Chest Radiograph
Over the course of 8 days, the patient developed progressive worsening multiorgan failure requiring a protective lung ventilator strategy for severe
acute respiratory distress syndrome (ARDS), ongoing vaspressor support, in addition to continuous renal replacement therapy. In the setting of
refractory hypoxaemia and progressive hypercapnia with conventional ventilatory support (Murray Score 3.25, pH 7.23), the patient was transferred to
the Karolinska Institute, Stockholm, Sweden for ECMO. The patient was initially treated with veno-venous ECMO but subsequently converted to veno-
arterial ECMO with nitric oxide secondary to venous stasis and right ventricular failure. Complications during the course of ECMO treatment included
spontaneous haemothorax requiring a thoracotomy, and ongoing gastrointestional bleeding prompting cessation of ECMO support on Day 11. The
patient was gradually weaned off pressure support ventilation over a 16 day period, and transferred back to Dublin. The total length of ventilatory
support including ECMO was 66 days and hospital stay was 78days. He recovered well with physical rehabilitation and retained full cognititive
function.
Discussion
Since 2009 H1N1 influenza A was first described and identified in Mexico in April 20093 a total of 4,586 laboratory confirmed cases of pandemic
(H1N1) influenza have been reported in Ireland ( 80% of cases aged ≤ 35 yrs)5. Of this patient group, 1,069 patients were hospitalized. 77 adult
patients required admission to an Intensive Care Unit and there were 14 adult ICU deaths (18% ICU mortality). Observational studies published to
date have recorded mortality rates ranging from 14.3%2,9 up to 41.4%3. ECMO is a treatment modality shown to be efficacious in the management of
neonatal and paediatric cardio-pulmonary failure6,7 and is indicated in adults with acute severe respiratory failure refractory to advanced modes of
mechanical ventilation. The Extracorporeal Life Support Organisation (ELSO) has reported survival rates of 85%, 74% and 52% in infants, children and
adults respectively treated with ECMO for severe Acute Respiratory Distress Syndrome (ARDS)5. This treatment technique involves the use a veno-
venous (preferred mode) or veno-arterial (required for cardiac support) life support circuit with a membrane oxygenator, and requires heparinisation.
Mechanical ventilator settings can then be adjusted to allow for lung rest, with lower respiratory rates, fraction of inspired O2 and plateau inspiratory
pressures (< 25 cm H2O) minimizing VALI8. 
An observational study of patients (n=68) with 2009 influenza A-associated ARDS treated with ECMO in 15 ICU’s in Australia and New Zealand
demonstrated an overall mortality of 21%9. Peek at al evaluated the safety, clinical efficacy, and cost-effectiveness of ECMO and established that early
transfer to an ECMO centre significantly improved survival without severe disability10. In the case that we have presented, transfer to the only Irish
institution providing a fixed non-mobile ECMO service (Mater Misericordiae University Hospital) was not possible as this facility was at full capacity.
Although an invasive and complex procedure, commencing ECMO in a specialised centre should be considered in patients with rapidly progressive
acute respiratory failure as a lifesaving measure when conventional mechanical ventilation and adjunctive non-ventilatory strategies have failed.
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